University Hospital, Caen
Clinical trials sponsored by University Hospital, Caen, explained in plain language.
-
New heart lead could simplify pacing for heart failure patients
Disease control Not yet recruitingThis study will test a new type of defibrillator lead designed to pace a specific area of the heart's electrical system. Researchers want to see if these leads can effectively treat heart failure while possibly reducing the number of leads needed. The study plans to enroll 200 pe…
Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could your GP spot heart trouble with a handheld ultrasound?
Diagnosis Not yet recruitingThis study explores whether general practitioners can use a tiny ultrasound device to detect early signs of heart disease during a routine office visit. Researchers will enroll 300 adults aged 65 and older with risk factors, or adults with symptoms like shortness of breath or leg…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Could a seawater balm soothe eczema as well as the gold standard?
Symptom relief Not yet recruitingThis study compares a new emollient balm made from seawater (Relipid+) to a leading balm (Lipikar) for mild to moderate eczema in people aged 6 months to 70 years. The goal is to see if the new balm works just as well at reducing symptoms and improving skin health. Researchers wi…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New study aims to find best pain relief for kids after circumcision
Symptom relief Not yet recruitingThis study compares two ways to numb the area for pain relief after circumcision in children: an ultrasound-guided penile block and a nerve-stimulation-guided pudendal block. Researchers want to see if the ultrasound method works just as well. About 240 children will take part to…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Music therapy tested to prevent caregiver burnout in Alzheimer's
Symptom relief Not yet recruitingThis study tests whether listening to music at home can improve the quality of life and reduce burnout in people caring for a loved one with Alzheimer's. Ninety caregiver-patient pairs will be split into groups, with some listening to music or podcasts three times a week for 12 w…
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 26, 2026 14:31 UTC
-
AI to predict heart damage from cancer treatments in major european study
Knowledge-focused Not yet recruitingThis study will collect data from up to 10,000 cancer patients across Europe to create better tools for predicting heart damage caused by certain cancer treatments. Researchers will use artificial intelligence alongside standard methods to develop risk scores that doctors can use…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Letter from your GP could save your life: new study aims to speed up colonoscopies
Knowledge-focused Not yet recruitingThis study tests whether sending an early letter with information about colonoscopy—either from the screening center alone or co-signed by the patient's own doctor—can increase the number of people who get a follow-up colonoscopy within 6 months of a positive colorectal cancer sc…
Phase: PHASE3 • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Can your lung bacteria predict Post-Transplant trouble?
Knowledge-focused Not yet recruitingThis study will follow 120 adults receiving a stem cell transplant to see if the types of viruses and bacteria in their lungs can predict future lung complications. Researchers will collect samples from the nose and lungs over time and analyze them using advanced genetic techniqu…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Baby drug dosing study aims to prevent post-surgery breathing problems
Knowledge-focused Not yet recruitingThis study will find the correct dose of sugammadex, a drug that reverses muscle relaxants, for infants under 2 years old. About 99 babies having non-emergency surgery will receive small, increasing doses until their muscle function returns. The goal is to ensure safe and complet…
Phase: PHASE4 • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New pacemaker technique aims to prevent heart rhythm problems
Knowledge-focused Not yet recruitingThis study tests a new way to place a pacemaker lead in the heart's upper chambers. The goal is to see if pacing a specific area (Bachmann's bundle) can keep the heartbeat more natural and reduce the risk of atrial fibrillation. About 200 adults who need a pacemaker will take par…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Tiny noses, big clues: study hopes nose bugs predict preterm lung disease
Knowledge-focused Not yet recruitingThis study follows 270 preterm babies (born before 32 weeks) from birth to age 3. Researchers will regularly swab their noses to analyze the bacteria and other microbes living there. The goal is to see if the nose microbiome can predict which babies will develop bronchopulmonary …
Phase: NA • Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
MS treatment failure: the hidden emotional toll on patients
Knowledge-focused Not yet recruitingThis study looks at how treatment failure impacts the quality of life, anxiety, depression, and daily activities of 150 adults with relapsing-remitting multiple sclerosis. Researchers will use questionnaires to measure patients' well-being and their experience with care. The goal…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Which cancer drug is safer for the heart? large study aims to find out
Knowledge-focused Not yet recruitingThis study looks at medical records of 15,000 adults with chronic B-cell cancers to compare the risk of developing atrial fibrillation (an irregular heartbeat) between two drugs, zanubrutinib and acalabrutinib. Researchers will analyze data from a health database to see which dru…
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC